BridgeBio | BiotechTV

top of page

Nov 21, 2023

BridgeBio's Neil Kumar reviews #AHA23 data and the company's pipeline and finances

Neil Kumar discusses the competitive profile he sees emerging for acoramidis, a big phase 3 in ADH1 and investing in early science.

BridgeBio's Neil Kumar on drug development

Apr 28, 2023

Company News

BridgeBio's Neil Kumar on drug development

BridgeBio's Neil Kumar shares experiences that may be good learnings for other drug developers and discusses his company's unique model.

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

The NYSE is the world’s largest stock exchange, offering icons and entrepreneurs the opportunity to raise capital and change the world. Our listed companies form a powerful community committed to good governance and societal impact. Industry-leading trading technology, combined with the guidance of experienced traders creates higher market quality for NYSE-market participants

Visit NYSE